Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, 100730, China.
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
BMC Microbiol. 2024 Sep 28;24(1):364. doi: 10.1186/s12866-024-03513-z.
BACKGROUND: Dysbiosis of the microbiome is a key hallmark of polycystic ovary syndrome (PCOS). However, the interaction between the host and microbiome and its relevance to the pathogenesis of PCOS remain unclear. METHODS: To evaluate the role of the commensal gut microbiome in PCOS, we gavaged germ-free mice with the fecal microbiota from patients with PCOS or healthy individuals and evaluated the reproductive endocrine features of the recipient mice. RESULTS: Mice transplanted with fecal microbiota from PCOS patients and those transplanted from healthy controls presented different bacterial profiles and reproductive endocrine features. The fecal microbiota of the mice in the PCOS group was enriched in Phocaeicola, Mediterraneibacter, Oscillospiraceae, Lawsonibacter and Rikenellaceae. Fecal microbiota transplantation (FMT) from PCOS patients induced increased disruption of ovarian functions, lipo-metabolic disturbance, insulin resistance and an obese-like phenotype in recipient mice. CONCLUSION: Our findings suggest that the microbiome may govern the set point of PCOS-bearing individuals and that gut ecosystem manipulation may be a useful marker and target for the management of PCOS.
背景:微生物组的失调是多囊卵巢综合征(PCOS)的一个关键标志。然而,宿主与微生物组之间的相互作用及其与 PCOS 发病机制的相关性尚不清楚。
方法:为了评估共生肠道微生物组在 PCOS 中的作用,我们将 PCOS 患者和健康个体的粪便微生物群移植到无菌小鼠中,并评估受体小鼠的生殖内分泌特征。
结果:移植来自 PCOS 患者粪便微生物群的小鼠和移植来自健康对照的小鼠表现出不同的细菌谱和生殖内分泌特征。PCOS 组的粪便微生物群富含 Phocaeicola、Mediterraneibacter、Oscillospiraceae、Lawsonibacter 和 Rikenellaceae。来自 PCOS 患者的粪便微生物群移植(FMT)可导致受体小鼠卵巢功能破坏、脂代谢紊乱、胰岛素抵抗和肥胖样表型增加。
结论:我们的研究结果表明,微生物组可能控制 PCOS 患者的设定点,肠道生态系统的操纵可能是 PCOS 管理的有用标志物和靶点。
Microbiol Spectr. 2024-8-6
BMC Microbiol. 2024-5-17
J Am Coll Nutr. 2020
J Endocrinol Invest. 2021-8
Front Biosci (Landmark Ed). 2024-5-30
Bioinformatics. 2023-8-1
Nat Biotechnol. 2024-5
PLoS Comput Biol. 2021-11
Trends Endocrinol Metab. 2021-8